Perry A - Search Results

1

Characterization of gliomas: from morphology to molecules.

Ferris SP, Hofmann JW, Solomon DA, Perry A. Ferris SP, et al. Among authors: perry a. Virchows Arch. 2017 Aug;471(2):257-269. doi: 10.1007/s00428-017-2181-4. Epub 2017 Jul 4. Virchows Arch. 2017. PMID: 28674742 Review.

2

Pathology of low-grade gliomas: an update of emerging concepts.

Perry A. Perry A. Neuro Oncol. 2003 Jul;5(3):168-78. doi: 10.1215/S1152851702000443. Neuro Oncol. 2003. PMID: 12816723 Free PMC article. Review.

3

Genetic markers in adult high-grade gliomas.

Pekmezci M, Perry A. Pekmezci M, et al. Among authors: perry a. Semin Radiat Oncol. 2014 Oct;24(4):235-9. doi: 10.1016/j.semradonc.2014.06.005. Semin Radiat Oncol. 2014. PMID: 25219807 Review.

4

Practical molecular pathologic diagnosis of infiltrating gliomas.

Pekmezci M, Perry A. Pekmezci M, et al. Among authors: perry a. Surg Pathol Clin. 2015 Mar;8(1):49-61. doi: 10.1016/j.path.2014.10.004. Epub 2014 Dec 4. Surg Pathol Clin. 2015. PMID: 25783821 Review.

5

Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations.

Solomon DA, Wood MD, Tihan T, Bollen AW, Gupta N, Phillips JJ, Perry A. Solomon DA, et al. Among authors: perry a. Brain Pathol. 2016 Sep;26(5):569-80. doi: 10.1111/bpa.12336. Epub 2015 Dec 14. Brain Pathol. 2016. PMID: 26517431 Free PMC article.

6

Histologic classification of gliomas.

Perry A, Wesseling P. Perry A, et al. Handb Clin Neurol. 2016;134:71-95. doi: 10.1016/B978-0-12-802997-8.00005-0. Handb Clin Neurol. 2016. PMID: 26948349 Review.

7

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. Louis DN, et al. Among authors: perry a. Acta Neuropathol. 2016 Jun;131(6):803-20. doi: 10.1007/s00401-016-1545-1. Epub 2016 May 9. Acta Neuropathol. 2016. PMID: 27157931 Review.

8

IDH1 mutation can be present in diffuse astrocytomas and giant cell glioblastomas of young children under 10 years of age.

Ferris SP, Goode B, Joseph NM, Kline CN, Samuel D, Gupta N, Bollen A, Perry A, Mueller S, Solomon DA. Ferris SP, et al. Among authors: perry a. Acta Neuropathol. 2016 Jul;132(1):153-5. doi: 10.1007/s00401-016-1579-4. Epub 2016 May 9. Acta Neuropathol. 2016. PMID: 27161253 Free PMC article. No abstract available.

9

Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide.

Wahl M, Phillips JJ, Molinaro AM, Lin Y, Perry A, Haas-Kogan DA, Costello JF, Dayal M, Butowski N, Clarke JL, Prados M, Nelson S, Berger MS, Chang SM. Wahl M, et al. Among authors: perry a. Neuro Oncol. 2017 Feb 1;19(2):242-251. doi: 10.1093/neuonc/now176. Neuro Oncol. 2017. PMID: 27571885 Free PMC article. Clinical Trial.

10

Activating NRF1-BRAF and ATG7-RAF1 fusions in anaplastic pleomorphic xanthoastrocytoma without BRAF p.V600E mutation.

Phillips JJ, Gong H, Chen K, Joseph NM, van Ziffle J, Jin LW, Bastian BC, Bollen AW, Perry A, Nicolaides T, Solomon DA, Shieh JT. Phillips JJ, et al. Among authors: perry a. Acta Neuropathol. 2016 Nov;132(5):757-760. doi: 10.1007/s00401-016-1616-3. Epub 2016 Sep 13. Acta Neuropathol. 2016. PMID: 27624885 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,071 results

Search Page